Evidence map›Paper›PMID 40061451›Full record

ArticleFrontiers in cellular and infection microbiology2025

Kyoungok Jang, Hangeun Kim, Dobin Choi, Soojin Jang, Dae-Kyun Chung

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyoungok Jang *Therapeutic Research Group, Antibacterial Resistance Laboratory, Institute Pasteur Korea, Seongnam-si, Gyeonggi-do, Republic of Korea.
Hangeun Kim *Research and Development Center, Skin Biotechnology Center Co. Ltd., Yongin, Republic of Korea.
Dobin ChoiGraduate School of Biotechnology, Kyung Hee University, Yongin, Republic of Korea.
Soojin JangTherapeutic Research Group, Antibacterial Resistance Laboratory, Institute Pasteur Korea, Seongnam-si, Gyeonggi-do, Republic of Korea.
Dae-Kyun ChungResearch and Development Center, Skin Biotechnology Center Co. Ltd., Yongin, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vimentin is an intermediate filamentous cytoskeletal protein involved in cell migration, adhesion, and division. Recent studies have demonstrated that several bacteria and viruses interact with vimentin to facilitate entry and trafficking within eukaryotic cells. However, the relationship between Methods: In the current study, we elucidated vimentin expression mechanism in human keratinocytes infected with Results: HaCaT cells increased vimentin expression through physical interaction with live Discussion: Thus, these experiments elucidated the mechanism of vimentin protein expression during

Indexed as

Host-Pathogen InteractionsKeratinocytesStaphylococcus aureusVimentinCell LineHaCaT CellsHumansNF-kappa BSignal TransductionToll-Like Receptor 2NF-kappa BTLR2 protein, humanToll-Like Receptor 2VimentinVIM protein, humanHaCaT cellskeratinocytesskin infectionStaphylococcus aureusTLR signalingvimentin

Identifiers

PMID40061451
PMCPMC11885264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.